These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dopamine D4 receptors: significance for molecular psychiatry at the millennium. Tarazi FI; Baldessarini RJ Mol Psychiatry; 1999 Nov; 4(6):529-38. PubMed ID: 10578234 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D4 receptors and development of newer antipsychotic drugs. Kulkarni SK; Ninan I Fundam Clin Pharmacol; 2000; 14(6):529-39. PubMed ID: 11206702 [TBL] [Abstract][Full Text] [Related]
4. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action. Wilson JM; Sanyal S; Van Tol HH Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018 [TBL] [Abstract][Full Text] [Related]
5. The importance of dopamine D4 receptors in the action and development of antipsychotic agents. Reynolds GP Drugs; 1996 Jan; 51(1):7-11. PubMed ID: 8741229 [TBL] [Abstract][Full Text] [Related]
6. The dopamine D4 receptors and mechanisms of antipsychotic atypicality. Wong AH; Van Tol HH Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1091-9. PubMed ID: 14642969 [TBL] [Abstract][Full Text] [Related]
7. [Functional role of dopamine D4 receptor in schizophrenia]. Semba J Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):13-20. PubMed ID: 15027326 [TBL] [Abstract][Full Text] [Related]
9. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment. de Almeida J; Mengod G Neuroscience; 2010 Nov; 170(4):1133-9. PubMed ID: 20727949 [TBL] [Abstract][Full Text] [Related]
10. Dopamine D4 receptors: a new opportunity for research on schizophrenia. Liégeois J; Eyrolles L; Bruhwyler J; Delarge J Curr Med Chem; 1998 Apr; 5(2):77-100. PubMed ID: 9481035 [TBL] [Abstract][Full Text] [Related]
11. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells. McAllister G; Knowles MR; Ward-Booth SM; Sinclair HA; Patel S; Marwood R; Emms F; Patel S; Smith A; Seabrook GR J Recept Signal Transduct Res; 1995; 15(1-4):267-81. PubMed ID: 8903944 [TBL] [Abstract][Full Text] [Related]
12. The dopamine D4 receptor: biochemical and signalling properties. Rondou P; Haegeman G; Van Craenenbroeck K Cell Mol Life Sci; 2010 Jun; 67(12):1971-86. PubMed ID: 20165900 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia. Ohara K; Nakamura Y; Xie DW; Ishigaki T; Deng ZL; Tani K; Zhang HY; Kondo N; Liu JC; Miyasato K; Ohara K Biol Psychiatry; 1996 Dec; 40(12):1209-17. PubMed ID: 8959285 [TBL] [Abstract][Full Text] [Related]
14. Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action. Sanyal S; Van Tol HH J Psychiatr Res; 1997; 31(2):219-32. PubMed ID: 9278187 [TBL] [Abstract][Full Text] [Related]
15. Heteromerization between α Casadó-Anguera V; Moreno E; Sánchez-Soto M; Cai NS; Bonaventura J; Homar-Ruano P; Rubinstein M; Cortés A; Canela EI; Ferré S; Casadó V Pharmacol Res; 2021 Aug; 170():105745. PubMed ID: 34182128 [TBL] [Abstract][Full Text] [Related]
16. The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group. Kramer MS; Last B; Getson A; Reines SA Arch Gen Psychiatry; 1997 Jun; 54(6):567-72. PubMed ID: 9193198 [TBL] [Abstract][Full Text] [Related]
17. Dopamine D3 and D4 receptor antagonists in the treatment of schizophrenia. Jardemark K; Wadenberg ML; Grillner P; Svensson TH Curr Opin Investig Drugs; 2002 Jan; 3(1):101-5. PubMed ID: 12054059 [TBL] [Abstract][Full Text] [Related]